Transplantation Biology
Post-liver transplantation virus reinfection can be delayed by early therapy
Published in Hepatitis Weekly, April 3rd, 2006
"Improved understanding of HCV dynamics during and after liver transplantation can be useful in optimizing antiviral therapy in transplant recipients," wrote K.A. Powers and colleagues, Los Alamos National Laboratory. "We analyzed serum HCV ribonucleic acid (RNA) levels during and after cadaveric liver transplantation in 6 HCV patients. After removal of the liver and before the new liver started producing virions, HCV RNA levels dropped with an average half-life (t(1/2)) of 0.8 hours."
The scientists observed, "Viral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-04-03)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
HBV replication is blocked by asialoglycoprotein receptor antisense oligonucleotides - Hepatitis C Virus
Anti-hepatitis C virus responses activated by a toll-like receptor - Hepatitis C Virus
HCV infection is mediated by a pH-dependent membrane fusion process - Hepatitis C Virus
Hepatitis C virus envelope functionally analyzed by cell-cell fusion assay - Hepatitis C Virus
Novel HCV vector overcomes anti-Ad5 immunity and induces immune responses - Adverse Drug Reaction
Hemoglobin reduction is associated with the use of erythrocyte ribavirin - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
